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sured by the CartiLaps ELISA assay and corrected for urinary
creatinine levels. We used log(uCTX-II) to have approximately
normally distributed marker values.
The BL distribution of KL scores was (145,88,30,24,1) for KL 0-4.
Among the BL healthy knees (KL 0), 101 were non-progressors
at FU (KL 0) and 25 were progressors (KL > 0).
The prognostic ability was evaluated on whether the biomarker
BL values separated progressors from non-progressors with
MANOVA statistical signiﬁcance and by sample size (n) and
odds ratio (OR) for predicting progression.
An aggregate biomarkers was made by combining all biomark-
ers and the cartilage longevity marker by combining uCTX-II
with cartilage volume and homogeneity by linear discriminant
analysis. They were evaluated by repeated random sampling
of disjoint training and evaluation subsets to avoid performance
overestimation due to overtraining.
Results: The table lists p value for separating progressors from
non-progressors with the corresponding n and OR for each
biomarker. Only the compartment with best performance is listed
for the MRI markers. Also age and BMI predicted progression
(p<0.01) but not congruity and sex.
Prediction of Progression (evaluated by MANOVA p-value, sample size n, and
odds ratio OR)
Biomarker P-value n OR
JSW 0.5 – –
uCTX-II 0.004 71 6.7
Volume (MF.VC) 0.08 218 2.8
Area (MT.AC) 0.07 216 2.8
Thickness (MT.ThCtAB) 0.2 – –
Smoothness (MT.SmoC) 0.01 118 3.8
Homogeneity (MT.HomC) 0.002 69 4.9
Aggregate: All markers 0.001 50 6.3
Aggregate: Cartilage Longevity
(uCTX-II, Homogeneity, Volume) 0.00003 29 14.6
Conclusions: The results demonstrated that both biochemical
and MRI-based biomarkers were suitable prognostic biomarkers
while JSW appeared unsuited. The best individual biomarker
was uCTX-II requiring n 71 and offering OR 6.7. However, the
cartilage longevity marker combining uCTX-II, homogeneity and
volume had n 29 and OR 14.6. This prognostic marker may there-
fore provide much stronger study population selection - allowing
clinical studies to show the true effect of potential treatments.
Furthermore, the longevity marker is intuitively appealing since it
combines aspects of cartilage quantity (volume), quality (homo-
geneity), and breakdown (uCTX-II) - the natural components in
a comprehensive prognosis on expected cartilage life-span.
65
AGGRECAN CONSISTS OF TWO DISTINCT POOLS: ONE
HIGH-MOLECULAR-WEIGHT, AGGRECANASE
DEGRADABLE REVERSIBLE POOL, AS WELL AS AN
IRREVERSIBLE, MMP-SUSCEPTIBLE
LOW-MOLECULAR-WEIGHT POOL
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P. Qvist, M.A. Karsdal
Nordic Bioscience, Herlev, Denmark
Purpose: Cartilage turnover consists of both physiological and
pathological turnover. Until now, these processes have not been
separated due to lack of molecular tools. Today, it is still debated
which family of enzymes that are the major players of aggre-
can degradation under pathological conditions. Previously, we
have shown that early stage aggrecanase-mediated aggrecan
degradation was fully reversible after catabolic stimulation with
Tumor Necrosis Factor Alpha (TNFα) and Oncostatin M (OSM) in
combination, followed by anabolic treatment with Insulin Growth
Factor-I (IGF-I), whereas late stage MMP-mediated degradation
was irreversible. In this study, we further investigated the time-
dependent degradation proﬁle of proteoglycans in cartilage with
focus on MMP and aggrecanase activity and characterized these
different molecules.
Methods: Cartilage depletion was stimulated in bovine artic-
ular cartilage explants by TNFα (20ng/ml) and Oncostatin M
(OSM) (10ng/ml) treatment. Cartilage degradation was measured
by two independent immunoassays: MMP-mediated aggrecan
degradation and aggrecanase-mediated aggrecan degradation,
342FFGVG-G2 and 374ARGSVI-G2 respectively. Glycosaminogly-
cans (GAGs) were quantiﬁed by a colorimetric assay. Cell culture
supernatants were further investigated by western blots by mon-
oclonal antibody against the MMP-generated 342FFGVG neo-
epitope, or the aggrecanase-generated 374ARGSVI sequence.
Importantly because of the location of the fragments in aggre-
can, in theory, MMP-generated fragments cannot be generated
secondary to aggrecanase cleavage, but the aggrecanase site
may be generated after MMP cleavage.
Results: Cytokine stimulation resulted in early release of
aggrecanase-mediated cartilage degradation fragments at day
7, as quantiﬁed by 374ARGSVI-G2, which was increased ap-
proximately 723% and GAGs were similarly elevated by 206%.
The increases were apparent until day 11 where aggrecanase-
mediated aggrecan depletion was exhausted. In contrast, MMP-
mediated aggrecan degradation began at day 16 until the end
of the study-period, resulting in a ﬁnal increase of 1598% of
342FFGVG-G2 fragments. Western blot analysis showed high
molecular weight GAG-entailing 374ARGSVI fragments at day 7,
in contrast to low molecular weight non-glycolysated 342FFGVG
analytes at day 21. When digesting OSM/TNFα stimulated ex-
plants from day 21 in vitro with ADAMTS-4, we observed a 225%
increase in the (374ARGSVI-G2/342FFGVG-G2) ratio (P=0.04).
Conclusions: This study demonstrates that two distinct pools of
aggrecan molecules exist in the articular cartilage. Secondary,
in contrast to previous publications that MMP-processed aggre-
can can be further degraded by aggrecanases. The pool of
high-molecular weight aggrecan, susceptible for aggrecanase-
mediated degradation, may be associated with fully reversible
cartilage degradation. In contrast, low molecular weight aggre-
can, degraded by MMPs may be associated with irreversible
cartilage destruction. These data begin to provide a molecular
understanding of reversible and non-reversible cartilage turnover.
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Purpose: Degradation of type II collagen is one of the hallmarks
of cartilage damage in osteoarthritis (OA). Urinary biochemical
markers reﬂecting the degradation of the helical (Helix-II) and
C-telopeptide (CTX-II) regions of type II collagen have been
developed and levels of both markers have been shown to
be associated with more rapid radiological progression in OA.
However, urinary markers have limitations including relatively
high imprecision due to variable urine dilution and the need for
creatinine correction. In addition a precise sampling of urine is
often difﬁcult in elderly patients. To overcome these limitations it
is useful to obtain serum-based biochemical markers. The aim
of our study was to investigate the association between serum
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levels of Helix-II measured by a new ELISA and radiological
progression in patients with knee OA followed prospectively for 5
years.
Methods: Eighty-three patients with persistent pain (> 3 months)
in one or both knees were included [54% female, mean age;
62 yr; Kellgren-Lawrence scores: 0 (13%), I (5%), II (4%), III
(77%), IV (1%)]. Serum for measurements of Helix-II and urinary
CTX-II were measured at baseline, 2 yr, 3 yr and 5 yr and
knee radiographs were obtained at baseline and 5 yr. Disease
progression was deﬁned as either a reduction in the tibiofemoral
joint space by at least 2 mm or total knee replacement of either
knee during the 5-year follow-up.
Results: During the 5-year follow-up, 24 patients had a radi-
ological progression and 59 did not progress. Serum Helix-II
increased during follow-up (10%/yr, p=0.0032) and mean 5-year
levels were higher in progressors than non-progressors (+30%,
p=0.0345). When used as a continuous variable, each SD in-
crease of mean 5 year serum Helix-II levels was associated
with an age-sex-BMI adjusted relative risk (RR) of progression
of 1.69 (95% conﬁdence interval: 1.01-2.81). In a multiple lo-
gistic regression model, both serum Helix-II and urinary CTX-II
were independently associated with disease progression. Pa-
tients with high serum Helix-II (highest quartile) and high urinary
CTX-II (above median) had an 8 fold higher risk of radiological
progression [RR: 7.79 (1.77-34.2)].
Conclusions: Increased serum Helix-II levels are associated
with a higher risk of radiological progression in knee OA in-
dependent of urinary CTX-II, suggesting that the two type II
collagen degradation markers reﬂect complementary biological
pathways of cartilage degradation. Overall, our data suggest that
the combination of serum Helix-II and urinary CTX-II would be a
more powerful predictor of disease outcome in knee OA.
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Purpose: To examine type II collagen content and denaturation
and their relationship in hip cartilages. The occurrence of similar
collagen molecule damage in knee and hip OA cartilage supports
the contention that collagen damage is a common feature in joint
disease.
Methods: 21 OA (aged 45 to 89 years, 13 women) and 26
reference (aged 55 to 99 years, 20 women) femoral heads
collected at total hip replacement surgery or in femoral neck
fracture patients were kept frozen at -80oC until analysis.
In OA, cartilage was sampled from areas that had full-thickness
cartilage whereas the reference cartilage was taken from the
superior mostly loaded area of femoral head. A small amount
of the 50 mg from each hip sampled cartilage was used for
routine histology to examine degradatavie changes according
to Mankin grading system (0-13). Each freeze- dried cartilage
sample was treated with 1mg/ml α-Chymotrypsin in 50 mM Tris
containing the proteinase inhibitors to extract denatured collagen.
The supernatants and residues were hydrolysed in 6N HCl at
110°C overnight, and then freeze-dried. These samples were
dissolved in 500µl of distilled water and clariﬁed using equal
amount of charcoal and AG-1 X8 anion exchange resin. The
amount of hydroxyproline was measured at 550 nm absorbance
by colorimetry. The L-4- Hyroxyproline was used as standard.
Results: The reference group was older than OA group
(p<0.001).
The median Manking grade in OA and reference samples were
4.5 (range 1-8) and 1 (range 0-3), respectively. In OA cartilage,
the collagen content was about 9% lower than that of reference
cartilages (1830 µg/ml vs. 2009 µg/ml, P=0.015). The proportion
of degraded collagen was almost four times higher in OA than
that of reference cartilages (3.7 vs. 1.1%) (P≤0.001).
There was no difference between men and women in collagen
content or degraded collagen in any of the groups.
There were no relationship between age and total collagen
content and no positive relationships between percent of collagen
denaturation and age in in reference or OA cartilages.
There was an inverse relationship between the percentages of
degraded collagen and collagen content in OA cartilage (r=-0.66,
p=0.001). In contrast, no obvious relationship between degraded
collagen and collagen content was present in the reference group
(p=0.17).
Conclusions: In the present study we extend previous ﬁndings of
increased amount of collagen degradation in knee OA and show
that similar changes also occur in hip OA. We also conﬁrm an
inverse relationship between collagen denaturation and content
in hip OA. The latter may represent a molecular explanation to
OA progression. At a higher rate of type II collagen damage,
lesser amount of collagen is maintained in the tissue. A possible
mechanism behind this is that released molecular fragments
may stimulate further extracellular matrix degradation causing
a vicious circle. This seems disease speciﬁc since an inverse
relationship between collagen degradation and content was not
obvious in reference cartilage.
Age is commonly discussed as a risk factor for OA since the
frequency of OA increases as population ages. In this study, col-
lagen content and degradation was not signiﬁcantly affected by
age. It suggests that OA may develop independently of age and
that OA in elder people may merely depend on long exposure
time to risk factors rather than age per se. In conclusion, the
present study provides new perspectives of cartilage collagen
metabolism in human OA cartilage. Similar molecular changes
occur in hip and knee OA cartilage seemingly without relation to
age. Therapeutic interventions in order to control joint cartilage
collagen content using inhibitors that decrease collagen degra-
dation ould be considered in the management of progressive hip
and knee OA.
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Purpose: Ageing is the primary risk factor for osteoarthritis (OA).
Chondrocytes in OA show a deviant behavior that resembles ter-
minal differentiation of growth-plate chondrocytes, characterized
by elevated MMP-13 expression. Previously we have demon-
strated a reduction in TGF-beta signaling via the ALK5 receptor
in aged mice and experimental OA. ALK5 activates the Smad2/3
route, which is known to suppress terminal differentiation. Re-
cently, it has been shown that in certain cell types TGF-beta is
also able to activate the Smad1/5/8 route via the ALK1 recep-
tor. This route has been shown to induce chondrocyte terminal
differentiation. We investigated whether during ageing and OA,
TGF-beta signaling switches from ALK5 to ALK1, favoring pro-
gression of chondrocyte differentiation.
Methods: We investigated whether TGF-beta signals via ALK5
or ALK1 in chondrocytes by Western blotting. To assess whether
ALK5 and ALK1 were speciﬁc for Smad2/3 or Smad1/5/8 re-
spectively, chondrocytes were transfected with Ad-caALK5 or
Ad-caALK1 after which a Western Blot was performed. Further-
